Treatment of patients with primary pulmonary hypertension (PPH) or secondary pulmonary hypertension (SPH) . Due to connective tissue disease or drug - induced, in moderate or severe stages of the disease. In addition, treatment of moderate or severe secondary pulmonary hypertension due to chronic pulmonary thromboembolism, where surgery is not possible.